Lava Therapeutics is a biotech company which develops proprietary T-cell engagers based on the scientific advancements of the VU University medical center in Amsterdam. The objective is to develop cost effective next generation immune oncology biopharmaceuticals delivering the primary targeted treatment in combination with immune recruiting and activating functionality.
|Employees (est.) (Jun 2018)||4|
Lava Therapeutics total Funding
Lava Therapeutics latest funding size
Time since last funding
|a month ago|
Lava Therapeutics investors
|LLC, Versant Ventures, Redmile Group, DeNovo Ventures, Ysios Capital, Gilde Healthcare, Sanofi Ventures, BB Pureos Bioventures|
When was Lava Therapeutics founded?
Lava Therapeutics was founded in 2016.
Who are Lava Therapeutics key executives?
Lava Therapeutics's key executives are Ton Adang, Hans van der Vliet and Paul Parren.
How many employees does Lava Therapeutics have?
Lava Therapeutics has 4 employees.
Who are Lava Therapeutics competitors?
Competitors of Lava Therapeutics include Shanghai Henlius Biotech, ImmunoCellular Therapeutics and Cellectar Biosciences.
Where is Lava Therapeutics headquarters?
Lava Therapeutics headquarters is located at 225 Onderwijsboulevard, 's-Hertogenbosch.
Where are Lava Therapeutics offices?
Lava Therapeutics has an office in 's-Hertogenbosch.
How many offices does Lava Therapeutics have?
Lava Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies